Your browser doesn't support javascript.
loading
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
Braulke, Friederike; Schulz, Xenia; Germing, Ulrich; Schuler, Esther; Platzbecker, Uwe; Nolte, Florian; Hofmann, Wolf-Karsten; Giagounidis, Aristoteles; Götze, Katharina; Lübbert, Michael; Schlenk, Richard F; Schanz, Julie; Bacher, Ulrike; Ganser, Arnold; Büsche, Guntram; Letsch, Anne; Schafhausen, Philippe; Bug, Gesine; Brümmendorf, Tim H; Haas, Rainer; Trümper, Lorenz; Shirneshan, Katayoon; Haase, Detlef.
Afiliación
  • Braulke F; Department of Hematology and Medical Oncology, University Medicine of Goettingen, Robert-Koch-Str. 40, 37075, Goettingen, Germany. friederike.braulke@med.uni-goettingen.de.
  • Schulz X; Department of Medical Statistics, University Medicine of Goettingen, Goettingen, Germany.
  • Germing U; Department of Hematology and Oncology, University of Duesseldorf, Duesseldorf, Germany.
  • Schuler E; Department of Hematology and Oncology, University of Duesseldorf, Duesseldorf, Germany.
  • Platzbecker U; Department of Hematology and Oncology, University of Dresden, Dresden, Germany.
  • Nolte F; Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.
  • Hofmann WK; Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.
  • Giagounidis A; Department of Hematology and Oncology, Marienhospital, Duesseldorf, Germany.
  • Götze K; Department of Hematology and Oncology, Technical University of Munich, Munich, Germany.
  • Lübbert M; Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
  • Schlenk RF; Department of Hematology and Oncology, University of Ulm, Germany, now National Center of Tumor Diseases, Heidelberg, Germany.
  • Schanz J; Department of Hematology and Medical Oncology, University Medicine of Goettingen, Robert-Koch-Str. 40, 37075, Goettingen, Germany.
  • Bacher U; Department of Hematology and Medical Oncology, University Medicine of Goettingen, Robert-Koch-Str. 40, 37075, Goettingen, Germany.
  • Ganser A; Department of Hematology, Hemostaseology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.
  • Büsche G; Institute of Pathology, Hannover Medical School (MHH), Hannover, Germany.
  • Letsch A; Departement of Hematology and Oncology, Charite University Medical Center Berlin, Berlin, Germany.
  • Schafhausen P; Department of Oncology, Hematology, BMT with section Pneumology, Hubertus Wald Cancer Center, Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bug G; Department of Internal Medicine II, Hematology and Oncology, Johann Wolfgang Goethe University of Frankfurt, Frankfurt, Germany.
  • Brümmendorf TH; Department of Hematology and Oncology, Hemostaseology and SCT, University Hospital RWTH Aachen, Aachen, Germany.
  • Haas R; Department of Hematology and Oncology, University of Duesseldorf, Duesseldorf, Germany.
  • Trümper L; Department of Hematology and Medical Oncology, University Medicine of Goettingen, Robert-Koch-Str. 40, 37075, Goettingen, Germany.
  • Shirneshan K; Department of Hematology and Medical Oncology, University Medicine of Goettingen, Robert-Koch-Str. 40, 37075, Goettingen, Germany.
  • Haase D; Department of Hematology and Medical Oncology, University Medicine of Goettingen, Robert-Koch-Str. 40, 37075, Goettingen, Germany.
Ann Hematol ; 96(6): 887-894, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28374162

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talidomida / Síndromes Mielodisplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talidomida / Síndromes Mielodisplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Alemania